Sentinel lymph node biopsy for cutaneous melanoma

A propos of 144 cases

Petros Konofaos, Dimitrios Karypidis, Chrisostomos Chrisostomidis, Epaminondas Kostopoulos, Gregorios Champsas, Othon Papadopoulos

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: The aim of this study was to identify the predictive factors of a positive sentinel lymph node (SLN) in patients with cutaneous malignant melanomas and tumor progression. Methods: From October of 2000 to January of 2006, 144 patients with cutaneous malignant melanoma underwent SLN biopsy. Patients were divided into two groups according to the SLN status (positive vs negative) which were compared with regards to patient demographics and primary tumor characteristics. Results: In 37 (25.69%) patients SLN biopsy was positive . Nodular melanomas (p=0.047), blood (p=0.010) and lymph (p<0.001) vessel infiltration, mitotic rate (p=0.019) and Breslow thickness (p=0.012) were predictive of a positive SLN biopsy. The overall recurrence, mortality and the overall disease free survival (DFS) rates were 6.25, 1.4 and 93.75, respectively. Conclusion: SLN biopsy is the most important predictor of early disease recurrence and survival in patients with cutaneous malignant melanoma. Considering all the examined factors, a positive SLN biopsy is related with Breslow thickness and lymph vessel infiltration.

Original languageEnglish (US)
Pages (from-to)263-272
Number of pages10
JournalJournal of B.U.ON.
Volume19
Issue number1
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Sentinel Lymph Node Biopsy
Melanoma
Skin
Lymph
Recurrence
Disease-Free Survival
Neoplasms
Survival Rate
Demography
Survival
Mortality
Cutaneous Malignant Melanoma

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Konofaos, P., Karypidis, D., Chrisostomidis, C., Kostopoulos, E., Champsas, G., & Papadopoulos, O. (2014). Sentinel lymph node biopsy for cutaneous melanoma: A propos of 144 cases. Journal of B.U.ON., 19(1), 263-272.

Sentinel lymph node biopsy for cutaneous melanoma : A propos of 144 cases. / Konofaos, Petros; Karypidis, Dimitrios; Chrisostomidis, Chrisostomos; Kostopoulos, Epaminondas; Champsas, Gregorios; Papadopoulos, Othon.

In: Journal of B.U.ON., Vol. 19, No. 1, 01.01.2014, p. 263-272.

Research output: Contribution to journalArticle

Konofaos, P, Karypidis, D, Chrisostomidis, C, Kostopoulos, E, Champsas, G & Papadopoulos, O 2014, 'Sentinel lymph node biopsy for cutaneous melanoma: A propos of 144 cases', Journal of B.U.ON., vol. 19, no. 1, pp. 263-272.
Konofaos P, Karypidis D, Chrisostomidis C, Kostopoulos E, Champsas G, Papadopoulos O. Sentinel lymph node biopsy for cutaneous melanoma: A propos of 144 cases. Journal of B.U.ON. 2014 Jan 1;19(1):263-272.
Konofaos, Petros ; Karypidis, Dimitrios ; Chrisostomidis, Chrisostomos ; Kostopoulos, Epaminondas ; Champsas, Gregorios ; Papadopoulos, Othon. / Sentinel lymph node biopsy for cutaneous melanoma : A propos of 144 cases. In: Journal of B.U.ON. 2014 ; Vol. 19, No. 1. pp. 263-272.
@article{032f2ffd956049d8950144d41c48b897,
title = "Sentinel lymph node biopsy for cutaneous melanoma: A propos of 144 cases",
abstract = "Purpose: The aim of this study was to identify the predictive factors of a positive sentinel lymph node (SLN) in patients with cutaneous malignant melanomas and tumor progression. Methods: From October of 2000 to January of 2006, 144 patients with cutaneous malignant melanoma underwent SLN biopsy. Patients were divided into two groups according to the SLN status (positive vs negative) which were compared with regards to patient demographics and primary tumor characteristics. Results: In 37 (25.69{\%}) patients SLN biopsy was positive . Nodular melanomas (p=0.047), blood (p=0.010) and lymph (p<0.001) vessel infiltration, mitotic rate (p=0.019) and Breslow thickness (p=0.012) were predictive of a positive SLN biopsy. The overall recurrence, mortality and the overall disease free survival (DFS) rates were 6.25, 1.4 and 93.75, respectively. Conclusion: SLN biopsy is the most important predictor of early disease recurrence and survival in patients with cutaneous malignant melanoma. Considering all the examined factors, a positive SLN biopsy is related with Breslow thickness and lymph vessel infiltration.",
author = "Petros Konofaos and Dimitrios Karypidis and Chrisostomos Chrisostomidis and Epaminondas Kostopoulos and Gregorios Champsas and Othon Papadopoulos",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
volume = "19",
pages = "263--272",
journal = "Journal of B.U.ON.",
issn = "1107-0625",
publisher = "Balkan Union of Oncology",
number = "1",

}

TY - JOUR

T1 - Sentinel lymph node biopsy for cutaneous melanoma

T2 - A propos of 144 cases

AU - Konofaos, Petros

AU - Karypidis, Dimitrios

AU - Chrisostomidis, Chrisostomos

AU - Kostopoulos, Epaminondas

AU - Champsas, Gregorios

AU - Papadopoulos, Othon

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Purpose: The aim of this study was to identify the predictive factors of a positive sentinel lymph node (SLN) in patients with cutaneous malignant melanomas and tumor progression. Methods: From October of 2000 to January of 2006, 144 patients with cutaneous malignant melanoma underwent SLN biopsy. Patients were divided into two groups according to the SLN status (positive vs negative) which were compared with regards to patient demographics and primary tumor characteristics. Results: In 37 (25.69%) patients SLN biopsy was positive . Nodular melanomas (p=0.047), blood (p=0.010) and lymph (p<0.001) vessel infiltration, mitotic rate (p=0.019) and Breslow thickness (p=0.012) were predictive of a positive SLN biopsy. The overall recurrence, mortality and the overall disease free survival (DFS) rates were 6.25, 1.4 and 93.75, respectively. Conclusion: SLN biopsy is the most important predictor of early disease recurrence and survival in patients with cutaneous malignant melanoma. Considering all the examined factors, a positive SLN biopsy is related with Breslow thickness and lymph vessel infiltration.

AB - Purpose: The aim of this study was to identify the predictive factors of a positive sentinel lymph node (SLN) in patients with cutaneous malignant melanomas and tumor progression. Methods: From October of 2000 to January of 2006, 144 patients with cutaneous malignant melanoma underwent SLN biopsy. Patients were divided into two groups according to the SLN status (positive vs negative) which were compared with regards to patient demographics and primary tumor characteristics. Results: In 37 (25.69%) patients SLN biopsy was positive . Nodular melanomas (p=0.047), blood (p=0.010) and lymph (p<0.001) vessel infiltration, mitotic rate (p=0.019) and Breslow thickness (p=0.012) were predictive of a positive SLN biopsy. The overall recurrence, mortality and the overall disease free survival (DFS) rates were 6.25, 1.4 and 93.75, respectively. Conclusion: SLN biopsy is the most important predictor of early disease recurrence and survival in patients with cutaneous malignant melanoma. Considering all the examined factors, a positive SLN biopsy is related with Breslow thickness and lymph vessel infiltration.

UR - http://www.scopus.com/inward/record.url?scp=84898857458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898857458&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 263

EP - 272

JO - Journal of B.U.ON.

JF - Journal of B.U.ON.

SN - 1107-0625

IS - 1

ER -